Navigation Links
Marketing and Meeting Details (M2D) Officially Launches an Innovative Life Sciences Marketing and Communications Company

Clients to Benefit from a Distinctive Union of Pharmaceutical, Biotech and Medical Device Experience in Professional Education, Brand Management and

Special Event Planning

NORTH BRANFORD, Conn., Nov. 19 /PRNewswire/ -- M2D management announces the official launch of a progressive marketing and communications firm that will focus on the life sciences sector. M2D is the brainchild of two individuals with clear records of success in this highly regulated sector, Christine Lawton and Timothy Roe.

(Logo: )

Christine is a respected meetings and events professional with almost two decades of experience working on both the client and agency sides of the business. Her accomplishments span several hundred meetings and conventions of all varieties, both domestically and internationally, during her pharmaceutical tenure.

Timothy is a pharmaceutical and medical device professional with over 15 years of progressively responsible positions in Sales and Marketing. Timothy is known in the industry as having the business acumen to maximize a product's global commercial return and asset value. Timothy has managed the "Big-C" brands, Celebrex(R), Cipro(R) and Clarinex(R) as well as several smaller niche products.

M2D provides tireless proactive thinking that eliminates problems associated with vendor complacency. Timothy Roe adds:

"As a former Product Manager, I recognize what is important to clients. Vendors should always add more detailed and proactive thought to their work, even after the 'honeymoon' period. There continues to be a tremendous need for much higher performance, and smaller firms like M2D are already there. Those who can do it cost-effectively will win."

M2D's uniqueness results from a lifetime of client-side interactions with vendors. Clients receive genuine strategic attention, but the difference lies with M2D's painstakingly detailed approach to tactical execution. The company utilizes the most advanced analytics and metric reporting tools available and offers them either gratis or at attractive pricing.

M2D's core capabilities include:

-- Thorough Understanding of Compliance Laws

-- Lowest Guaranteed Travel Rates

-- Investigator & Sales Meetings

-- Conventions & Symposia; Ad Boards & Round Tables

-- Opinion Leader & Speaker Bureau Management

-- Promotional Peer-to-Peer Events

-- CME-based Programming

-- Surrogate Brand Management and Audits

-- Advanced Webinars & Web Conferences with Real-Time Polling

M2D's website

Celebrex, Cipro and Clarinex are products of Pfizer, Bayer and Schering- Plough respectively.

Contact: M2D Media Relations

Phone: 781-210-4710

Fax: 781-210-4711


SOURCE Marketing and Meeting Details (M2D)
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
2. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
3. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
4. Fitness Champion Natalie Waples to be Spokesperson for Natural Nutrition International Direct Marketing Campaign
5. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
6. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
7. Sterling Life Enhances Marketing Operations Controls to Better Serve Medicare Beneficiaries
8. Former Ronco President Tim Dupler Signs International Direct Sales and Marketing Contract with Natural Nutrition
9. Eastern Alliance Insurance Group Appoints Cox Regional Marketing Director for Southeast
10. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
11. Scientific Publications Strategy & Delivery Shifts from Marketing to Medical
Post Your Comments:
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... for oncology and hematology continuing medical education (CME), today announced that the first ... Grand Hyatt New York. , “The prevention, detection and treatment of gastrointestinal cancers ...
(Date:12/1/2015)... ... December 01, 2015 , ... Speech and physical therapies ... with innovative technologies and under the right circumstances, these practices can be merged. ... a dual-approach to his or her therapeutic sessions, as well as gives the ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... 7th Annual 2015 Golden Bridge Business Awards under the New Products and Services ... capex web based sample management software that helps labs organize data ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of volumetric breast ... focus of numerous abstracts accepted for presentation here, at the 101st Annual Radiology ... highlight the use of Volpara Solutions’ quantitative breast imaging software tools for providing ...
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... Health Center of Excellence (BHCOE) today announced that the organization has awarded Education ... San Francisco, with a Distinguished Award. The award celebrates exceptional special needs providers ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 --> ... Drugs Market by Type of Drug (Monoclonal Antibodies, Interferon-Alpha, Interleukins, ... and Pipeline Analysis - Global Forecast to 2020", published by ... USD 73,529.2 Million by 2020 from USD 40,281.6 Million in ... Browse 37 market data ...
(Date:12/1/2015)... Virginia , 1 de diciembre de ... en tecnología para cuchillas de precisión, develó ... programa de identidad de marca. El nuevo ... el diseño y la ingeniería de productos ... la diferencia". ...
(Date:12/1/2015)... , Dec. 1, 2015 During ... in San Francisco, CA , ... to the coronary marketplace. During a satellite symposium, ... Stent Design to Minimize Restenosis", a renowned physician ... available Medinol NIRxcell™ CoCr Coronary Stent System and ...
Breaking Medicine Technology: